食管癌外泌体介导的恶性表型研究及肿瘤转移相关基因1(MTA1)相关外泌体的定量蛋白质组学分析
本文选题:MTA1 + 外泌体 ; 参考:《北京协和医学院》2017年硕士论文
【摘要】:目的探讨食管癌外泌体介导的肿瘤细胞之间的恶性表型传递以及MTA1对食管癌细胞外泌体特性及蛋白成分影响。方法采用差速超速离心法提取KYSE410细胞外泌体,通过透射电镜及免疫印迹法(Western blotting)观察所获得的外泌体的形态及其标志物;共聚焦显微镜观察KYSE410、KYSE510和YES2细胞摄取荧光染料标记的KYSE410外泌体;分别采用transwell实验、划痕愈合实验、细胞增殖实验、克隆形成实验检验KYSE410细胞外泌体对3种食管癌细胞迁移、侵袭、增殖和克隆形成的影响;免疫印迹法检测Wnt/β-catenin和PI3K/Akt信号通路相关蛋白的变化。分别对MTA1共表达基因和MTA1 Co-IP质谱相互作用蛋白作聚类分析;Nanosight检测不同MTA1表达水平的食管癌细胞分泌的外泌体粒径大小;Label-free质谱方法检测不同MTA1表达水平的食管癌细胞的外泌体蛋白并对差异蛋白作GO功能聚类分析;通过CCLE数据库和cBioPortal平台数据分析MTA1和目标差异蛋白在组织、细胞水平的相关性;分析目标差异蛋白与临床病理特征的相关性。结果透射电镜可以观察到具有膜结构的外泌体;免疫印迹方法能够检测到外泌体标志蛋白CD63和CD81;3种细胞均能够成功摄取荧光染料标记的KYSE410外泌体;3种食管癌细胞的迁移及侵袭能力从大到小依次为KYSE410、KYSE510、YES2,KYSE410外泌体能够促进3种食管癌细胞迁移、侵袭及克隆形成,但不影响3种食管癌细胞的增殖;外泌体处理能够增强3种食管癌细胞中β-catenin和p-Akt的表达。MTA1共表达基因聚类分析显示MTA1影响囊泡组织与生物合成;MTA1 Co-IP质谱相互作用蛋白聚类分析显示绝大多数MTA1相互作用蛋白在外泌体中有定位;不同MTA1表达水平的KYSE410细胞和KYSE450细胞分泌的外泌体的大小和数量没有显著差异;首次鉴定出25个新的外泌体蛋白成分;CytoScape软件分析两组外泌体蛋白连接度最高的节点均在UBC蛋白;对照/敲除MTA1的KYSE410细胞获得外泌体蛋白和对照/过表达KYSE450细胞获得的外泌体蛋白都主要定位在胞浆、细胞核、溶酶体、质膜等部位,主要的分子功能包括催化活性、分子伴侣活性、细胞骨架蛋白结合、GTPase活性等,主要影响的生物学进程包括蛋白代谢、能量通路、细胞生长和维持、免疫反应等;广泛参与整联蛋白家族细胞表面相互作用、β1整联蛋白细胞表面相互作用、蛋白多糖syndecan介导的信号事件等;对照/敲除MTA1的KYSE410细胞和对照/过表达KYSE450细胞的外泌体内MTA1调控的差异蛋白共同参与大分子代谢负调控、磷酸盐代谢、大分子分解代谢等生物学进程;MYH9、SLC7A5和CCT4均与MTA1在组织水平有中等强度相关性;MYH9、CCT4和食管癌病人T分期、临床分期有相关性;SLC7A5、CCT4高表达的食管癌病人总生存时间更短。结论高侵袭性食管癌细胞KYSE410来源的外泌体能够促进自身以及食管癌KYSE510、YES2细胞的迁移和侵袭、克隆形成,其可能是通过激活Wnt/β-catenin和PI3K/Akt信号通路发挥上述作用的。聚类分析结果表明MTA1可能参与外泌体调控;MTA1不影响食管癌细胞分泌外泌体的大小和总量;但MTA1影响食管癌细胞外泌体的蛋白质组成;关键的差异蛋白MYH9、SLC7A5、CCT4可能作为食管癌的预后评价指标。
[Abstract]:Objective to investigate the malignant phenotype transmission between tumor cells mediated by esophageal carcinoma and the effects of MTA1 on the extracellular secretory and protein components of esophageal cancer cells. Methods the extracellular secretory of KYSE410 cells was extracted by differential velocity centrifugation, and the morphology of the exosecrete obtained by transmission electron microscopy and immunoblotting (Western blotting) was observed and the morphology of the exosecrete was observed by transmission electron microscopy and immunoblotting (blotting). Its markers; confocal microscopy (confocal microscopy) to observe the KYSE410 Exocyst marked by KYSE410, KYSE510 and YES2 cells with fluorescent dye; Transwell experiment, scratch healing experiment, cell proliferation experiment, and clone formation test were used to test the effect of KYSE410 cell exocrine on the migration, invasion, proliferation and cloning of 3 kinds of esophageal cancer cells. The changes of Wnt/ beta -catenin and PI3K/Akt signal pathway related proteins were detected by trace method. The MTA1 coexpression gene and MTA1 Co-IP mass interaction protein were cluster analysis respectively; Nanosight was used to detect the outer secretory particle size of esophageal cancer cells with different MTA1 expression levels, and the Label-free spectrum method was used to detect the esophagus with different MTA1 expression levels. The exocrine protein of cancer cells was analyzed by GO function cluster analysis, and the correlation of MTA1 and target differential protein in tissue and cell level was analyzed by CCLE database and cBioPortal platform data, and the correlation between target differential protein and clinicopathological features was analyzed. The immunoblotting method can detect the exosecreting protein CD63 and CD81, and 3 kinds of cells can successfully absorb the KYSE410 exote marked by fluorescent dyes; the migration and invasion ability of the 3 esophageal cancer cells from large to small are KYSE410, KYSE510, YES2, and the KYSE410 exote can promote the migration, invasion and cloning of 3 kinds of esophageal cancer cells. The proliferation of 3 esophageal cancer cells was not affected; exosecretory treatment enhanced the expression of.MTA1 co expression genes in 3 esophageal cancer cells and.MTA1 co expression gene cluster analysis showed that MTA1 affects vesicle tissue and biosynthesis; MTA1 Co-IP mass spectrometry interaction protein cluster analysis showed that most of MTA1 interacting proteins were determined in exosecrete. There was no significant difference in the size and quantity of exocrine secreted by KYSE410 and KYSE450 cells at different levels of MTA1 expression; 25 new exocrine proteins were identified for the first time; CytoScape software analyzed the nodes with the highest degree of exocytosis of the two groups in UBC protein; and the exocrine protein was obtained for KYSE410 cells that were illuminated / knocked out of MTA1. The exosecreting proteins obtained from the controlled / overexpressed KYSE450 cells are mainly located in the cytoplasm, nucleus, lysosome, plasma membrane and other parts. The main molecular functions include catalytic activity, molecular chaperone activity, cytoskeleton binding, and GTPase activity. The main effects of biological processes include protein metabolism, energy pathway, cell growth and dimension. Holding, immune responses, and so on; widely involved in the cell surface interaction of the integrin family, the surface interaction of the beta 1 integrin cells, the signaling events mediated by the proteoglycan syndecan, and the negative modulation of the MTA1 KYSE410 cells and the control / overexpressed KYSE450 cells in the MTA1 regulation of the exocrine KYSE450 cells. Biological processes such as control, phosphate metabolism, macromolecular catabolism and other biological processes; MYH9, SLC7A5 and CCT4 have moderate correlation with MTA1 at the tissue level; MYH9, CCT4 and esophageal cancer patients have a correlation of T staging and clinical staging; SLC7A5 and CCT4 high expression of esophageal cancer have shorter total survival time. Conclusion high invasive esophageal cancer cells are of KYSE410 origin. Exosecrete can promote the migration and invasion of KYSE510 and YES2 cells in the carcinoma of the esophagus and the formation of the clone formation, which may be played by activating the Wnt/ beta -catenin and PI3K/Akt signaling pathway. Cluster analysis results show that MTA1 may be involved in exocrine regulation; MTA1 does not affect the size and total amount of exocrine secreted by cancer cells; but MTA 1 the protein composition of exocrine cells in esophageal cancer may be affected. The key differentially expressed proteins MYH9, SLC7A5 and CCT4 may be used as prognostic indicators for esophageal cancer.
【学位授予单位】:北京协和医学院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R735.1
【相似文献】
相关期刊论文 前9条
1 苏琳杰;;引进惠民技术 造福一方百姓——记商洛市中心医院引进开展食管癌微创技术[J];新西部;2014年04期
2 胡艳霞;张秀霞;;食管癌术后心律失常的原因分析及护理对策[J];当代护士(下旬刊);2014年05期
3 段太蓉;;食管癌术后早期肠内营养支持的护理体会[J];四川医学;2014年04期
4 徐亚英;陆美琴;;跨理论模型干预对食管癌手术患者生活质量的影响[J];当代护士(下旬刊);2014年05期
5 杨磊;肿瘤转移相关基因mta1和肿瘤[J];医学综述;2003年01期
6 何妮;赵荫农;;肿瘤转移相关基因MTA1与肿瘤关系的研究进展[J];中国医学文摘(肿瘤学);2005年03期
7 李广旭;宋平平;贾慧;李浩;张曙光;张百江;;食管癌新辅助放化疗患者血清肿瘤标记物水平动态变化及意义[J];山东医药;2014年10期
8 宋毅,黄光琦,唐尧;一种候选的转移相关基因MTA1在卵巢癌中的表达[J];肿瘤;2003年03期
9 钱锦贤;李定彪;洪志鹏;;肿瘤转移相关基因MTA1在肿瘤中的研究进展[J];云南医药;2008年05期
相关博士学位论文 前7条
1 杨颖涛;白细胞介素10基因多态性与食管癌的关系及其机制研究[D];郑州大学;2017年
2 杨哲;分子标志物在食管癌同期放化疗中的指导价值研究[D];山东大学;2017年
3 霍小东;ZEB2在食管癌侵袭转移中的作用及其机制研究[D];天津医科大学;2017年
4 王晓敏;食管癌容积旋转调强放疗计划剂量学临床相关研究[D];郑州大学;2017年
5 许猜;食管癌最新放射治疗技术剂量学和临床研究结果分析胸腺瘤复发模式和复发胸腺瘤治疗结果分析[D];北京协和医学院;2017年
6 葛晓晴;miR-193a-5p下调ERBB2表达抑制食管鳞状细胞癌侵袭的机制研究[D];郑州大学;2017年
7 王湛;E-cadherin、β-catenin、MMP16在食管癌中的表达及与化疗疗效的关系及对食管癌细胞化疗敏感性的影响[D];郑州大学;2017年
相关硕士学位论文 前10条
1 林锋;食管癌外泌体介导的恶性表型研究及肿瘤转移相关基因1(MTA1)相关外泌体的定量蛋白质组学分析[D];北京协和医学院;2017年
2 江兰芳;miR-a和miR-503在食管癌发生发展中的作用及机制研究[D];北京协和医学院;2017年
3 魏毅;3.0T MR食管癌成像与病理对照研究[D];郑州大学;2017年
4 梁淑影;食管鳞状细胞癌TP53突变研究[D];郑州大学;2017年
5 张晓锋;食管癌患者施行PET-CT检查相关人员辐射剂量估算与评价[D];郑州大学;2017年
6 张仁锋;原代食管癌干细胞的分离及初步鉴定[D];郑州大学;2017年
7 田亚兰;虾青素油剂干预NMBzA诱导的F344大鼠食管癌效果及机制研究[D];郑州大学;2017年
8 李莉莉;查尔酮衍生物cc-85调节活性氧诱导食管癌细胞凋亡的作用机制研究[D];郑州大学;2017年
9 徐子舒;沙利度胺联合化疗治疗晚期食管鳞癌的临床观察[D];郑州大学;2017年
10 王玲玲;FADS2基因在食管鳞状细胞癌中的表达及其生物学功能的初步探究[D];郑州大学;2017年
,本文编号:2055616
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2055616.html